Elevated blood microplastics and their potential association with Parkinson's disease

Area of Science:

• Environmental Science
• Neuroscience
• Toxicology

Background:

• Microplastic (MP) presence in human blood is under-investigated.
• A potential link between MP exposure and Parkinson's disease (PD) requires further study.

Purpose of the Study:

• To quantify and characterize MPs in the blood of PD patients and healthy controls.
• To explore the association between MP exposure and PD.
• To investigate the neurotoxic effects of specific MPs in vitro.

Main Methods:

• Blood samples collected from 21 PD patients and 12 controls using anticontamination protocols.
• MP analysis via Pyrolysis-Gas Chromatography-Mass Spectrometry (Py-GC/MS), Laser Direct Infrared imaging (LDIR), and Scanning Electron Microscopy (SEM).
• In vitro assays on dopaminergic neurons exposed to PVC and PP MPs.

Main Results:

• Five polymer types (PE, PS, PVC, PP, PA66) detected in blood samples.
• Significantly higher total MP burden in PD patients (21.36 ± 8.42 μg/g) compared to controls (13.56 ± 5.92 μg/g).
• PVC, PP, and PA66 showed the most significant increases in PD patients; PVC and PP MPs induced dopaminergic neuron apoptosis and increased phosphorylated α-synuclein (p-α-syn).

Conclusions:

• PD patients exhibit elevated blood microplastic levels.
• Preliminary evidence suggests a link between microplastic exposure (particularly PVC and PP) and neurotoxicity relevant to PD.
• Further research is warranted to elucidate the role of microplastics in PD pathogenesis.